Evidence map›Paper›PMID 38216201›Full record

ArticleBMJ open2024

Cross-sectional survey of sexual health professionals' experiences and perceptions of the 2022 mpox outbreak in the UK.

Rosalie Hayes, Francesca Dakin, Melanie Smuk, Sara Paparini, Vanessa Apea, Claire Dewsnap, L Waters, Jane Anderson, Chloe M Orkin

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. A rapidly developing outbreak of clade Ib mpox among gay, bisexual and other men who have sex with men associated with severe proctitis, Northern Ireland, June 2026.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Rosalie HayesSHARE Collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.ORCID 0000-0003-4046-4101
Francesca DakinNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Melanie SmukSHARE Collaborative, Blizard Institute, Queen Mary University of London, London, UK.
Sara PapariniSHARE Collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Vanessa ApeaSHARE Collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Claire DewsnapSexual Health, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
L WatersMortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK.
Jane AndersonSHARE Collaborative, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Chloe M OrkinSHARE Collaborative, Blizard Institute, Queen Mary University of London, London, UK c.m.orkin@qmul.ac.uk.ORCID 0000-0001-6168-6745
Queen Mary University of London · GBCentral and North West London NHS Foundation Trust · GBSheffield Teaching Hospitals NHS Foundation Trust · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo understand the experiences and perceptions of sexual health professionals responding to the May 2022 mpox outbreak in the UK.

designCross-sectional, anonymous, online survey collecting quantitative and qualitative data. Convenience sample recruited via an international network of sexual health and HIV clinicians responding to mpox and promoted through clinical associations and social media. Survey domains included: clinical workload; preparedness, support, and training; safety at work; vaccination; and well-being. Qualitative descriptive analysis of open-text responses was conducted to support interpretation of the quantitative data.

participantsParticipants who were employed as sexual health professionals in the UK and had direct clinical experience of mpox were included in the analysis. The survey was completed between 11 August and 31 October 2022 by 139 respondents, the majority of whom were doctors (72.7%), cis-female (70.5%) and White (78.4%).

results70.3% reported that they were required to respond to mpox in addition to their existing clinical responsibilities, with 46.8% working longer hours as a result. In the open-text data, respondents highlighted that workload pressures were exacerbated by a lack of additional funding for mpox, pre-existing pressures on sexual health services, and unrealistic expectations around capacity. 67.6% of respondents reported experiencing negative emotional impact due to their mpox work, with stress (59.0%), fatigue (43.2%) and anxiety (36.0%) being the most common symptoms. 35.8% stated that they were less likely to remain in their profession because of their experiences during the mpox outbreak. In the open-text data, these feelings were ascribed to post-COVID exhaustion, understaffing and frustration among some participants at the handling of the mpox response.

conclusionsThese findings indicate that sexual health services require increased funding and resources, along with evidence-based well-being interventions, to support sexual health professionals' outbreak preparedness and recovery.

Indexed as

Mpox, MonkeypoxSexual HealthCross-Sectional StudiesDisease OutbreaksFemaleHumansUnited KingdomCross-Sectional StudiesHealth policyHealth WorkforcePublic healthSEXUAL MEDICINE

Identifiers

PMID38216201
PMCPMC10806624
OpenAlexW4390830550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.